Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Long-Term Debt Repayments (2020 - 2022)

Historic Long-Term Debt Repayments for Iterum Therapeutics (ITRM) over the last 3 years, with Q1 2022 value amounting to $2.3 million.

  • Iterum Therapeutics' Long-Term Debt Repayments rose 3818.29% to $2.3 million in Q1 2022 from the same period last year, while for Dec 2022 it was $2.3 million, marking a year-over-year decrease of 6545.43%. This contributed to the annual value of $2.3 million for FY2022, which is 6545.43% down from last year.
  • Per Iterum Therapeutics' latest filing, its Long-Term Debt Repayments stood at $2.3 million for Q1 2022, which was up 3818.29% from $1.6 million recorded in Q4 2021.
  • In the past 5 years, Iterum Therapeutics' Long-Term Debt Repayments ranged from a high of $2.3 million in Q1 2022 and a low of $1.6 million during Q2 2020
  • Over the past 3 years, Iterum Therapeutics' median Long-Term Debt Repayments value was $1.6 million (recorded in 2021), while the average stood at $1.7 million.
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first surged by 323.19% in 2021, then soared by 3818.29% in 2022.
  • Iterum Therapeutics' Long-Term Debt Repayments (Quarter) stood at $1.6 million in 2020, then grew by 3.23% to $1.6 million in 2021, then soared by 38.18% to $2.3 million in 2022.
  • Its last three reported values are $2.3 million in Q1 2022, $1.6 million for Q4 2021, and $1.6 million during Q3 2021.